Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas S Werner

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacology|August 23, 2018
A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Target-Directed Self-Assembly of Homodimeric Drugs Against β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Journal of Medicinal Chemistry|February 15, 2020
Novel, Self-Assembling Dimeric Inhibitors of Human β TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Plos One|April 16, 2015
Reversible linkage of two distinct small molecule inhibitors of Myc generates a dimeric inhibitor with improved potency that is active in myc over-expressing cancer cell linesJutta Wanner, Darlene Romashko, Douglas S Werner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IRMeizhong Jin, Prafulla C Gokhale, Andy Cooke, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2Andrew P Crew, Shripad V Bhagwat, Hanqing Dong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacology|August 23, 2018
A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Target-Directed Self-Assembly of Homodimeric Drugs Against β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Journal of Medicinal Chemistry|February 15, 2020
Novel, Self-Assembling Dimeric Inhibitors of Human β TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Plos One|April 16, 2015
Reversible linkage of two distinct small molecule inhibitors of Myc generates a dimeric inhibitor with improved potency that is active in myc over-expressing cancer cell linesJutta Wanner, Darlene Romashko, Douglas S Werner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IRMeizhong Jin, Prafulla C Gokhale, Andy Cooke, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2Andrew P Crew, Shripad V Bhagwat, Hanqing Dong, et al.
Pageof 1